ATM and breast carcinoma: Pathogenic variants in CHEK2, ATM, and PALB2 are thought to confer a breast cancer risk that is above the 20% lifetime threshold for which breast magnetic resonance imaging is considered.24,27 Thus identifying pathogenic variants in any of these three genes in particular can have clear implications for clinical management.